Biofrontera (BFRI) Other Accumulated Expenses (2024 - 2026)
Biofrontera (BFRI) posted quarterly Other Accumulated Expenses of $320000.0 for Q4 2025, down 47.8% year-over-year from $613000.0 in Q4 2024, and down 53.01% quarter-over-quarter from $681000.0 in Q3 2025.
Biofrontera (BFRI) Other Accumulated Expenses (2024 - 2026) Analysis & Trends
Biofrontera's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $320000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 47.8% year-over-year to $320000.0; the TTM figure through Dec 2025 stood at $320000.0 (down 47.8% YoY), while the FY2025 annual figure was $320000.0, down 47.8% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $320000.0, down from $681000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $683000.0 in Q2 2025, with the low at $320000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 217,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 681,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 613,000.00 |